InChI=1S/C15H22FN3O6/c1- 3- 4- 5- 6- 24- 15(23) 18- 12- 9(16) 7- 19(14(22) 17- 12) 13- 11(21) 10(20) 8(2) 25- 13/h7- 8,10- 11,13,20- 21H,3- 6H2,1- 2H3,(H,17,18,22,23) /t8- ,10- ,11- ,13- /m1/s1 |
GAGWJHPBXLXJQN-UORFTKCHSA-N |
CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O |
|
antimetabolite
A substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
|
|
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
|
capecitabina
|
ChEBI
|
capécitabine
|
ChEBI
|
capecitabine
|
KEGG DRUG
|
capecitabinum
|
ChEBI
|
(1- (5- Deoxy- beta- D- ribofuranosyl)- 5- fluoro- 1,2- dihydro- 2- oxo- 4- pyrimidinyl)- carbamic acid pentyl ester
|
KEGG COMPOUND
|
Capecitabin
|
ChEBI
|
pentyl 1- (5- deoxy- β- D- ribofuranosyl)- 5- fluoro- 1,2- dihydro- 2- oxo- 4- pyrimidinecarbamate
|
ChemIDplus
|
Pentyl [1- (5- deoxy- β- D- ribofuranosyl)- 5- fluoro- 2- oxo- 1,2- dihydropyrimidin- 4- yl]carbamate
|
IUPAC
|
154361-50-9
|
CAS Registry Number
|
ChemIDplus
|
8583270
|
Reaxys Registry Number
|
Reaxys
|
|